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ABSTRACT 
Lifetime risk of atrial fibrillation by race and socioeconomic status: The Atherosclerosis 
Risk in Communities (ARIC) study 
          Atrial fibrillation (AF) is a common cardiac arrhythmia, affecting 2.7-6.1 million people in 
the US. The lifetime risk of AF has been previously reported in whites, but not in African 
Americans. Lifetime risk of AF by socioeconomic status has not been investigated before. This 
study investigated the lifetime risk of AF in African Americans and in individuals with different 
socioeconomic status. The analysis included 15,343 whites and African Americans in the 
Atherosclerosis Risk in Communities (ARIC) study who were followed for an average of 21 
years. For analysis, total family income was categorized as <$25,000, $25,000-$49,999, and 
≥$50,000, and education as < high school graduate, high school graduate, and at least some 
college. Incident AF was ascertained from study electrocardiograms, hospital discharge records, 
and death certificates. Lifetime risk of AF was estimated by a modified Kaplan-Meier method. 
2760 AF cases were identified during follow-up. Lifetime risk of AF was 36% (95% CI: 32-
38%) in white men, 30% (26-32%) in white women, 21% (13-24%) in African American men, 
and 22% (16-25%) in African American women. Regardless of race and sex, incidence rates of 
AF decreased from the lowest to highest categories of income and education. In contrast, lifetime 
risk of AF increased in individuals with higher income and education in most sex-race groups. 
Cumulative incidence of AF was lower in those with higher income and education compared to 
their low socioeconomic status counterparts through earlier life but was reversed after age 85. 
The study concluded that lifetime risk of AF in the ARIC cohort was approximately 33% among 
whites and 20% among African Americans. Socioeconomic status was inversely associated with 
cumulative incidence of AF before the last decades of life. 
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INTRODUCTION 
Background 
          Atrial fibrillation (AF) affects 2.7-6.1 million people in the United States. This number is 
expected to increase as the population ages. 1 It is estimated that by 2030 there will be 12.1 
million AF cases in the US. 41 AF is associated with significant morbidity, mortality, and poor 
quality of life, as it can lead to blood clots and increase the risk of heart failure (HF), myocardial 
infarction (MI), 3 and stroke. 4 Risk factors for AF include high blood pressure, obesity, diabetes, 
smoking, and heavy drinking.42 
          AF constitutes a significant public health burden. Annual cost of AF in the US is 
approximately $6 billion, and people who have AF spend an additional $8,705 per year on 
medical costs compared to people without AF. 1, 2  
          Findings from the Framingham Heart Study in 2004 indicated that one in four individuals 
would develop AF during their lifetime,5 with recent estimates in the same cohort suggesting that 
lifetime risk of AF is greater 30%. 6 Lifetime risk quantifies the absolute risk of developing a 
disease of interest before death. It is calculated as the adjusted cumulative incidence of the 
disease, taking the competing risks of death into account. 5 Estimates of the lifetime risk of 
developing AF are an easy way to communicate future risk to individuals. 5 However, the recent 
Framingham estimates, though taking into account recent upward trends in the incidence of AF, 7 
may not be generalizable to non-white populations because its participants are from a 
predominantly white population of European origin.  Since African Americans and other ethnic 
and racial groups have lower risk of AF compared to whites,8, 9 contemporary estimates of 
lifetime risk of AF in more diverse populations are needed. 
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          Socioeconomic and racial health disparities exist in the US, 10 which influences health 
outcomes, including the management and care of cardiovascular diseases. 11 A previous analysis 
of the US-based Atherosclerosis Risk in Communities (ARIC) study cohort showed that lower 
income in the overall population and lower education level among women were associated with 
increased risk of AF. 12 To date, however, no study has explored the lifetime risk of AF by 
socioeconomic status (SES). 
          Therefore, to address these gaps, data from over 25 years of follow-up among 15,343 
participants in the ARIC study was used to provide estimates of lifetime risk of AF by race and 
SES. These estimates can provide a more precise picture of the current and future public health 
burden of AF in the growingly diverse US populations. 
Research Questions 
          What is the AF incidence in whites, African Americans, and individuals with distinguished 
SES in ARIC cohort? What is the lifetime risk of AF in ARIC cohort? What is the lifetime risk 
of AF in African Americans? What are lifetime risks of AF in groups of different SES?  
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LITERATURE REVIEW 
Lifetime risk of AF 
          A well-cited paper 5 from the Framingham Heart Study in 2004 reported that the lifetime 
risk for developing AF is 25% for men and women aged 40 years and older. The study included 
3999 men and 4726 women followed from 1968 to 1999. The lifetime risk of AF was estimated 
to the age of 95. The study showed that from the index age of 40, the lifetime risk of AF was 
26% [95% confidence interval (CI), 24% - 27%] for men and 23% (21% - 24%) for women, but 
it did not change significantly with the increase of the index ages. At the age of 80, the lifetime 
risk of AF was 23% (20% - 24%) in men and 22% (19% - 23%) in women. Recently, another 
analysis 6 from the same cohort of Framingham Heart Study shows that the lifetime risk of AF is 
37% after the age of 55 and 22% (95% CI, 15% - 29%) among individuals with low risks and 
48% (95% CI, 41% - 55%) with high risks. This recent analysis found a higher lifetime risk of 
AF than that reported in 2004 from the same cohort. In Europe, a prospective cohort study 
conducted in Sweden 20 found that the lifetime risk of AF was 23% among the male participants 
who were followed from the age of 50 to 98 years. The study indicated that among the cohort of 
855 men born in 1913, 185 developed AF before the age of 98. Another large European 
population-based study 21 demonstrated that the lifetime risk of AF was 24% in men and 22% in 
women at the age of 55. This study assessed 6808 participants followed for an average of 6.9 
years. 
Prevalence and incidence of AF 
          Studies have shown the AF prevalence and incidence in the white population. A study 7 of 
the Framingham Heart Study investigated the 50-year trends of incidence and prevalence of AF 
by dividing time into 10-year groups (1958-67, 1968-77, 1978-87, 1988-97, and 1998-2007) in 
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the analyses.  It found that from 1958 to 2007 the age-adjusted prevalence of AF increased from 
20.4 to 96.2 cases per 1000 person-years in men and from 13.7 to 49.4 cases per 1000 person-
years in women and the age-adjusted incidence increased from 3.7 to 13.4 and 2.5 to 8.6 new 
cases per 1000 person-years in men and women, respectively. The prevalence of AF diagnosed 
by electrocardiograph (ECG) increased from 12.6 in 1958-67 to 25.7 in 1998-2007 per 1000 
person-years in men and from 8.1 to 11.8 in women, while the incidence of AF diagnosed by 
ECG remained unchanged during the same period. The Sweden study of 855 men 20 reveals that 
the prevalence of AF was 0.4% among men aged 50 years, 1.9% by the age of 60, 4.6% by 70, 
12.5% by 80, and 15.7% by 90 years old, clearly indicating the prevalence was increasing as 
people age. Another prospective European study found that the overall prevalence was 5.5% 
(0.7% in the age of 55-59 years and 17.8% in individuals ≥ 85 years) and that the incidence was 
1.1 per 1000 person-years in the age of 55-59 and 20.7 per 1000 person-years in the age ≥ 80 
years. The study also found that men had higher prevalence and incidence than women.  
          Other studies also revealed the AF prevalence and incidence in diverse populations. 8, 9 An 
analysis 8 of the Atherosclerosis Risk in Communities (ARIC) study found that the crude 
incidence rates of AF were 6.7, 4.0, 3.9, and 3.0 per 1000 person-years in white men, white 
women, African American men, and African American women, respectively. The risk of AF in 
African Americans was lowered 41% (95% CI, 8% - 62%), compared with whites. Another 
multi-ethnic study 9 included 6721 participants followed by a mean period of 7.3 years. The 
study showed that the AF incidence in Hispanics, Non-Hispanic Blacks, and Chinese was 
significantly lower than that in Non-Hispanic Whites. An investigation on the US emergency 
room visit and the hospital admission 22 revealed that from 1993 to 2004 there were 2.7 million 
emergency room visits due to AF in the US and the visit rate was increased from 0.6 to 1.2 per 
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1000 people during this period. The number of visits was increased 88% over the span of 12 
years. Another analysis 24 on patients with pacemakers indicated that the prevalence of AF in 
African Americans was 21%, 95% (CI, 20%-23%) and was significantly lower than whites 
(26%, 95% CI, 25%-26%).  
Health disparity and AF 
          Studies consistently show the existence of health disparity in the US. African Americans 
have greater risks of cardiovascular diseases, such as hypertension and hyperlipidemia, obesity, 
and diabetes 10. An analysis 12 of ARIC study confirmed that low family income (< $25K per 
year) is associated with increased AF risk (hazard ration 1.45, 95% CI, 1.27 – 1.67), compared 
with high income (≥ $50k per year). It also found much higher AF risk (hazard ratio 1.88, 95% 
CI, 1.55 – 2.28) in women of low education status than those with high educational level. In 
addition, another ARIC study found that the rates of stroke, heart failure, coronary heart disease 
(CHD), and mortality were higher in African Americans diagnosed with AF, compared with their 
white counterparts. The observed rate differences were distinct among African Americans and 
whites. Heart failure and CHD were found to be 1.5 – 2 folds higher in African Americans than 
whites.  Approximately 56% (95% CI, 48% - 64%) mortality rate difference was observed in 
whites with AF and those without AF. For African Americans with AF and without AF, the 
difference was 106% (95% CI, 86% - 126%). Moreover, another retrospective study on patients 
with AF 32 concluded that the all-cause mortality is associated with SES. The study used the SES 
score determined by household income, the value of house unit, occupation, and education as a 
predictor of mortality, and found that the AF patients with low SES scores had significantly 
higher mortalities than their SES counterparts. 
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METHODS 
Study population 
          The basic design of ARIC has been described by other authors. 8, 13 Briefly, the 
Atherosclerosis Risk in Communities (ARIC) study is a prospective cohort study for the 
investigation of risk factors for cardiovascular diseases. 8, 13 During 1987 to 1989, 15,792 
participants (55% women, 27% African Americans) 45 to 64 years old were enrolled in the 
study. The participants were sampled from 4 US communities: Washington County, MD; the 
northwest suburbs of Minneapolis, MN; Jackson, MS; and Forsyth County, NC. The racial 
composition of the cohort reflected the underlying populations, except in Jackson, MS, where 
only African Americans were sampled. Baseline information was collected by a phone interview 
and a clinical examination. Subsequently, participants were examined 3 times at roughly 3-year 
intervals until 1998, with a fifth examination taking place in 2011-2013. During follow-up, 
participants were contacted annually by phone to gather information on hospital admission and 
verify vital status. The response rates on the triennial exams and the annual phone interview were 
93%, 86%, 80%, and >90%, respectively. For this analysis, we included follow-up information 
through December 31, 2014. The ARIC study has been approved by the Institutional Review 
Boards at the participating institutions. All the participants signed a written informed consent. 
          Among the 15,792 participants, the following was excluded from the analysis: 48 with 
self-reported race of non-white or non-African American and 55 African Americans in the study 
centers of MN and MD because of the small sample sizes; 37 with AF or atrial flutter diagnosed 
by ECG at the baseline visit; and 310 whose ECG was missing or unreadable at the baseline 
visit. In total, 15,343 participants were included as the study population. For the analysis by total 
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family income and education,893 whose income information was missing and 24 whose 
education information missing were excluded, respectively, in the corresponding analysis. 
Incidence of AF events 
          The ascertainment method for AF has been reported previously. 8, 12 In brief, AF was 
identified by three sources: ECGs from follow-up exams, hospital discharge records, and death 
certificates. ECGs during follow-up exams were done with MAC PC personal Cardiographs. All 
ECGs were transmitted to the ARIC ECG reading center for coding, interpretation, and storage. 
A trained cardiologist visually read recordings of ECGs automatically coded as AF for the 
certainty of the diagnosis. Also, hospitalization information was obtained during the annual 
follow-up interview and from surveillance of local hospitals. In ARIC, a trained abstractor 
accessed the hospital discharge records and recorded all the diagnoses according to International 
Classification of Diseases, Ninth Revision Clinical Modification (ICD-9-CM). AF was defined if 
codes 427.31 or 427.32 were present in the absence of procedure codes for open heart surgery. 
Finally, information on death from any cause was collected by calling participant’s proxy, or 
from obituaries, hospital records, death certificates, or vital statistics from the National Death 
Index. 14 Cases of AF were identified from death certificates if ICD-10 code I48 or ICD-9 code 
427.3 were listed as one of the causes of death. The validity of this approach for AF event 
identification, with a positive predictive value of approximately 90%, has been demonstrated 
previously. 8  
          The incidence date of AF was defined as the first occurrence of AF in an ECG during 
follow-up exam, a hospital discharge record, or death certificate. 8  
Assessment of SES and covariates 
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          The total family income and individual education level were self-reported during the 
baseline visit conducted by ARIC researchers. For the analysis, the total family income was 
categorized into three groups: < $25,000 per year; $25,000 to < $50,000 per year; and ≥ $50,000 
per year. In subgroup analysis related to African Americans, the last two groups were combined 
into one as ≥ $25,000 per year due to the small number of African American participants with 
reported income ≥ $50,000. Education level was also categorized into three groups: Basic – less 
than high school; Intermediate – high school or equivalent; and High– completed at least some 
college education. 
          Risk factors for cardiovascular disease were measured at baseline. Smoking status was 
self-reported. Participant’s height was measured without wearing shoes, and weight wearing 
light clothing. Blood pressure was measured three times at each visit after a 5-minute rest and in 
sitting position. The average of the last two measurements was used for the study. Blood 
pressure ≥ 140/90 mmHg or taking medications for hypertension was defined as hypertension. 
As it has been used in other studies, fasting blood glucose ≥ 126 mg/dl, non-fasting blood 
glucose ≥ 200 mg/dl, current treatment for diabetes, or self-reported physician-diagnosis of 
diabetes was defined as diabetes mellitus. 15 Self-reported history of myocardial infarction (MI) 
or electrocardiographic evidence of prior MI was characterized as prevalent MI. 15 Prevalent 
heart failure (HF) was identified using the Gothenburg criteria, or treatment of HF in the past 
two weeks at baseline. 15, 17 
          To study the association of short-time risk of AF with lifetime risk, the individual 
predicted 5-year risk of AF was calculated based on a previously described predictive risk 
model. 18 The model includes the following variables: age (years divided by 5), race (white or 
African American), height (10 cm), weight (15 kg), systolic (20 mmHg) and diastolic blood 
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pressure (10 mmHg), smoking status (current), the presence of treatment of hypertension with 
medications (yes), diabetes (yes), HF (yes), and history of MI (yes). It can be calculated as  
1 – 0.9718412736exp(ΣβX – 12.5815600). 18 
Statistical analysis 
          Participants’ characteristics at baseline are presented as percentages for the categorized 
variables and mean (standard deviation) for the continuous and stratified by race.  
          Age-specific rates of AF by 10-year group for age 45-54, and 5-year groups starting at age 
55 through age 92 (oldest attained age) were computed. Incidence rates were calculated dividing 
the number of new cases in an age-specific group by the corresponding person-years of follow-
up. Person-years of follow-up were defined from the date of visit 1 to the first diagnosis of AF, 
death, loss of follow-up, or December 31, 2014, whichever occurred first. The crude incidence 
rate was calculated as the total number of AF events divided by total person-years of follow-up. 
Rates were age-standardized using the age-specific distribution of person-years in the entire 
cohort as the standard population. 
          The modified Kaplan-Meier method was used to account for the competing risk of death 
by calculating the lifetime risk of AF (cumulative incidence through oldest attained age in the 
cohort), as reported previously. 19 In the computation of cumulative incidence adjusted for 
competing risk, the survival analysis was performed by taking death into account as the event of 
interest together with AF but not censored. Survival free of AF and being alive was a more 
appropriate condition than being free of AF but not alive when death was censored. Lifetime risk 
through age 92 (oldest age at which an AF event occurred in the cohort) starting at the index age 
45, 55, 65, and 75 was calculated. The separate calculations by race, sex, total family income, 
education level, and predicted 5-year AF risk according to quartiles of the CHARGE-AF score 
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were conducted. This later analysis was performed to estimate lifetime risk of AF across 
categories of short-term (5-year) AF risk. 
          SAS 9.4 (SAS Inc., Cary, NC) was used for the analysis. 
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RESULTS 
Characteristics of participants at baseline 
           There were 15,343 participants aged 45-64 years and without AF at baseline. Table 1 
shows participants’ characteristics by race and sex, while Table 2 reports characteristics by race, 
family income, and education. African Americans had the higher prevalence of cardiovascular 
events than whites, while white men had higher predicted 5-year risk of AF than other groups. 
As shown in Table 2, among both whites and African Americans, the lower income groups had a 
higher proportion of women (63% in whites and 67% in African Americans) compared to the 
other income groups, and those in the lowest categories of income and education had more 
adverse cardiovascular risk factors: higher systolic blood pressure (SBP) and higher prevalence 
of hypertension, diabetes, HF, and MI, and smoking. Overall, higher income and education were 
correlated with more favorable cardiovascular profile, and across categories of income and 
education, whites had a lower prevalence of cardiovascular risk factors than African Americans. 
AF incidence and lifetime risk by race and sex  
          The average follow-up period was 21 (+7SD) years. During the 1987 – 2014, follow-up 
period, 2,790 new cases of AF (2,270 in whites and 520 in African Americans) were identified. 
Incidence rates of AF rose with age across all gender and race groups, whites showing a higher 
rate (9.1 per 1,000 person-years) than African Americans (6.8 per 1,000 person-years) overall. 
Table 3 presents the age-, race-, and sex-specific incidence rates of AF per 1,000 person-years 
from 1987 to 2014. Age-standardized rates were highest (11.3 per 1,000 person-years) among 
white men (WM) and lowest (6.1 per 1,000 person-years) among African American women 
(AAW). Compared to WM, the rate ratios (RR) and 95% confidence interval (CI) of AF in 
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AAW, African American men (AAM), and white women (WW) were 0.54 (0.47, 0.61), 0.71 
(0.62, 0.83), and 0.64 (0.59, 0.70), respectively. 
          The lifetime risk of AF at the age 45 to 92 in whites was 33% and in African Americans 
21%, or approximately 1 in 3 and 1 in 5, respectively. Lifetime risk was 36% in WM, 30% in 
WW, 21% in AAM, and 22% in AAW. Table 4 displays the lifetime risk by race and sex at the 
index age of 45, 55, 65, and 75. The lifetime risk of AF remained almost constant from index age 
45 to 65, with slightly smaller values after index age 75. Figure 1 shows the cumulative 
incidence of AF from age 45 to 92 by race and sex. 
AF incidence and lifetime risk by income and education 
            Table 5 shows the age-, race-, income-, and education-specific AF incidence rates per 
1,000 person-years from 1987 to 2014. Overall, regardless of race and sex, AF incidence rates 
decreased as income and education increase. Compared to those with the lowest income, 
individuals in the highest income category had age-standardized relative rate reduction of 24% 
(WM), 30% (WW), 20% (AAM), and 27% (AAW). Corresponding values for high education 
versus low education were 21%, 43%, 29%, and 37% in WM, WW, AAM, and AAW, 
respectively. 
          Table 6 provides lifetime risk of AF by race, sex, income, and education conditional on 
survival free of AF from index age 45 to 75. In contrast to the clear association of higher income 
and education with lower rates of AF, lifetime risk of AF was higher in those with higher income 
and education. The only exception was estimates among WW, in which those with higher 
income and education had lower lifetime risk of AF than their more socioeconomically 
disadvantaged counterparts. Figure 2 presents the cumulative incidence of AF from age 45 to 92 
by income and education in WM, WW, AAM, and AAW. The figure shows that earlier in life, 
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cumulative incidence of AF is lower among those with higher income and education, but that 
trend is reversed after the age of 80 years. The only exception was WW who experienced lower 
AF cumulative incidence from the lowest to the highest categories of income and education 
during their entire lifetime. 
Lifetime risk of AF by predicted AF risk 
           With the purpose of estimating long-term risk of AF across categories of short-term 
predicted AF risk, an estimate of the lifetime risk of AF by quartiles of the predicted 5-year AF 
risk was calculated from the predictive model at baseline (see methods for variables included in 
the predictive model). Lifetime risk across quartiles of predicted 5-year risk at baseline was 11% 
for those with predicted risk ≤ 0.4%, 25% for predicted risk > 0.4% and ≤ 0.8%, 29% for 
predicted risk > 0.8% and ≤ 1.5%, and 37% for those with predicted risk > 1.5%, as shown in 
Table 7. Figure 3 presents the cumulative incidence of AF by quartiles of predicted 5-year risk of 
AF during age 45-92. The cumulative incidence positively increased with the predicted risk. The 
individuals having the highest predicted risk of AF showed more dramatic increase of 
cumulative incidence from age 45 to 92 compared to their counterparts who possessed lower 
predicted risk of AF. 
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DISCUSSION AND CONCLUSION 
          In this analysis of 15,343 men and women followed for an average of 21 years, estimated 
lifetime risk of developing AF was approximately 1 in 3 among whites and 1 in 5 among African 
Americans. The higher rates of AF with old age, among whites, and in individuals with lower 
socioeconomic status was observed. In contrast, the lifetime risk of AF was lower in individuals 
with low versus high socioeconomic status in most race-sex groups, possibly due to longer 
survival among the socioeconomically advantaged. Even among those with the lowest short-term 
predicted risk of AF, lifetime risk was considerable (>10%). 
          The current results complement those from an earlier analysis of the ARIC cohort with 
follow-up through 2004 (compared to 2014 in the present analysis). 8 The overall results from the 
two analyses are consistent, showing higher incidence rates of AF in whites than in African 
Americans, in men than in women, and exponential rate increases with age. However, because of 
more incident AF cases in the older cohort due to the extended follow-up, the crude incidence 
rates of AF increased from 6.7 to 11.5 per 1,000 person-years in white men, from 4.0 to 7.5 in 
white women, from 3.9 to 7.2 in African American men, and from 3.0 to 5.7 in African 
American women, compared with the previous ARIC report. 8 
          AF incidence rates in white men and white women in the ARIC cohort are comparable to 
the rates reported in a recent analysis of the Framingham Heart Study, 7 reflecting the general 
occurrence of AF in the white population in the US. Also, it was found that AF lifetime risk is 
around 1 in 3 in whites (36% in white men and 30% in white women) after the age of 45 years, 
which is higher than the lifetime risks reported in a previous analysis of the Framingham Heart 
Study, 5 the Swedish Study of Men Born in 1913, 20 and the Dutch Rotterdam Study,21 but 
similar to a recent report from the Framingham Heart Study. The increased AF lifetime risk may 
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partially be attributed to enhanced surveillance for and awareness of AF in the community. 7 Of 
note, follow-up in the older Framingham Heart Study and Rotterdam Study publications ended 
before the year 2000. 5, 21 Also, differences in AF risk factors and lifestyles across cohorts might 
explain the differences. For example, the prevalence of diabetes and MI in the ARIC cohort was 
higher than that in the Rotterdam Study. 21 Differences in the lifetime risk of AF between the 
current ARIC report and the recent Framingham Heart Study 6 can be explained by 
dissimilarities in the ascertainment of AF, which rely mostly in hospitalizations in ARIC, while 
the Framingham Heart Study had access to outpatient medical records.  
          Multiple studies have demonstrated that African Americans have lower incidence of AF 
than whites. In an earlier analysis of the ARIC study, it was found that AF rates in African 
Americans were 41% lower compared to whites after an average 15-year follow-up. 8 The same 
results have been found in different cohorts. 22 – 28 Complementing previous studies, I now show 
that African Americans have lower lifetime risk of AF than whites, despite higher prevalence of 
AF risk factors. However, notwithstanding their lower lifetime risk, still 1 in 5 African 
Americans in ARIC were estimated to develop AF during their lifetime, certainly not a trivial 
figure. It was also found that unlike whites, African American women had a slightly increased 
lifetime risk compared to African American men. The reason might be that African American 
women could live longer to very old age to have more chance of developing AF than African 
American men. In fact, African American women have lower all-cause mortality and longer life 
expectancy than African American men. 29    
          Prior research has reported higher rates of cardiovascular disease, including AF, among 
those with lower SES. 30 – 34 As expected, I found that age-standardized incidence rates of AF 
decreased in a dose-response fashion with higher income and education, regardless of race and 
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sex. The findings here are consistent with a previous ARIC report that specifically focused on 
examining the association between SES and AF incidence. 12 
          In contrast to the inverse association of SES with AF rates, I found that AF lifetime risk 
increased with income in WM, AAM, and AAW, and with education in WM and AAM. In this 
analysis, it was found that cumulative incidence of AF was generally lower earlier in life among 
those with higher income but increased substantially in the last decade of life among those with 
higher SES. Consistent with my findings, a prior study showed that the association between 
mortality risk and SES was attenuated in older people. 34 One potential explanation for this 
observation is the impact of mortality as a competing risk disproportionally affecting the 
socioeconomically disadvantaged groups. As shown in this analysis, ARIC participants in the 
lowest ranks of income and education had the highest prevalence of cardiovascular risk factors. 
Consequently, mortality would be higher in people with low income and education compared to 
others and, therefore, fewer people in low income and education would survive to old age to 
have a chance to develop AF. This may result in more AF in people with high income and 
education at the very late stage of life. In summary, estimates of lifetime risk of AF across SES 
groups may be problematic because it could mask actual socioeconomic disparities in the 
incidence of the arrhythmia. 
          The findings have significant implications for public health. The observation that 1 in 3 
whites and 1 in 5 African Americans will develop AF during their lifetime underscore the high 
burden of AF in the community. The increased number of AF patients has brought about an 
increased demand for anticoagulation treatment for stroke prevention, 35 and highlights the need 
for more randomized trials to evaluate strategies to reduce risk of ischemic events associated 
with AF. 36 The impact of AF is exacerbated by the increased risk of stroke, HF, and mortality in 
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persons affected by AF. 37 – 40 Hence, novel prevention approaches for AF and its complications 
are urgently needed overall and specifically in low SES individuals and other vulnerable groups, 
such as African Americans, who experience more AF-related adverse clinical outcomes. 14 
Strengths and limitations 
          This study is the first to report the lifetime risk of AF in African Americans. It takes 
advantage of the data available in the ARIC cohort, one of the longest follow-up studies in a 
large biracial population in the US. In addition to the diverse population, the large number of AF 
events, and the extended follow-up, other strengths include the excellent cohort retention and the 
careful methodology for ascertainment of cardiovascular events and mortality.  
       There are certain limitations in the study. More importantly, ascertainment of AF is likely to 
be incomplete since asymptomatic cases and those exclusively managed in the outpatient settings 
were missing. False negatives of AF possibly existed because the cardiologist was not visually 
examining the negative ECGs. Also, AF can be intermittent, and therefore may not be detected 
with a standard 10-second ECG and hospitalizations. In addition, the information on education 
and total family income was self-reported and collected only at baseline. Although the individual 
education status might not change after baseline, the total family income of some participants 
could change during the > 20 years of follow-up. While the total family income of other 
participants remained constant, this change might affect the result of the analysis. Moreover, the 
impact of education and income in the ARIC study reflects the experience of a cohort born 
between the 1920s to early 1940s, which may be different from those of later cohorts.  
Conclusions  
          Lifetime risk of AF in a contemporary cohort is approximately 36% among whites, higher 
than previously reported, and 25% among African Americans. These results contribute to clarify 
24 
 
the public health impact of AF and can be used to raise awareness of this common condition 
among the population. The findings also emphasize the importance of developing programs on 
screening and prevention of AF in low SES populations. 
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Table 1. Baseline characteristics of participants, Atherosclerosis Risk in Communities 
Study, 1987-1989 
  White men White women 
African American 
men 
African American 
women 
N 5332 5948 1539 2524 
Incidence AF cases 1263 1009 212 309 
Age, years 55 (6) 54 (6) 54 (6) 53 (6) 
%  35 39 10 16 
Height, cm 176 (7) 162 (6) 176 (7) 163 (6) 
Weight, kg 85 (14) 70 (15) 85 (17) 82 (18) 
BMI 27 (4) 27 (6) 28 (5) 31 (7) 
SBP, mmHg, mean 120 (16) 117 (18) 130 (22) 128 (22) 
DBP, mmHg, mean 73 (10) 70 (10) 82 (13) 78 (12) 
Smoking, % 25 25 38 25 
Antihypertension therapy, % 20 20 34 45 
Prevalence of diabetes, % 10 8 18 21 
Prevalence of HF, % 3 5 5 9 
Prior MI, % 7 1 5 3 
Predictive 5-year risk, % 0.02 (0.02) 0.01 (0.01) 0.01 (0.01) 0.01 (0.01) 
Estimated glomerular 
filtration rate 97 (13) 101 (12) 107 (19) 110 (20) 
Values correspond to means (standard deviations) or percentages. HF: Heart failure. MI: 
myocardial infarction. CHARGE-AF score: Predicted 5-year risk of AF 
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Table 2. Baseline Characteristics of participants by race, family income, and education, 
Atherosclerosis Risk in Communities Study, 1987 - 1989 
 Whites (n=11,280) 
 Total Family Income Education Levels 
 <$25K $25K-<$50K ≥$50K Basic Median High 
N 2874 4569 3337 1844 4890 4046 
% of total 26.7 42.4 31 17.1 45.4 37.5 
AF cases 683 917 58 491 1007 768 
Age, years 57(6) 54(6) 53(5) 56(5) 54(6) 54(6) 
% of female 62 51 46 50 59 46 
Height (women), cm  161(6) 162(6) 163(6) 160(6) 162(6) 163(6) 
Height (men), cm  174(7) 176(7) 178(6) 174 (6) 176(7) 178(6) 
Weight, kg 76(16) 78 (16) 78 (16) 78 (16) 76(16) 78(16) 
BMI 28(5) 27(5) 26(4) 28(5) 27(5) 27(4) 
SBP, mmHg 122(18) 119 (17) 116 (16) 122 (18) 119(17) 117(16) 
DBP, mmHg 71(10) 72(10) 72(10) 71(10) 72(10) 72(10) 
Smoking, % 30 25 20 35 26 19 
AT, % 26 20 15 26 21 16 
P. of diabetes, % 14 9 6 15 9 7 
P. of HF, % 6 3 2 6 4 3 
Prior MI, % 6 4 3 8 4 3 
 African-Americans (n=4,063) 
 <$25K ≥$25K Basic Median High 
N 2598 1055 1529 1035 1089 
% of total 71.1 28.9 41.9 28.3 29.8 
AF cases 366 26 258 142 119 
Age, years 54(6) 52(5) 55 (6) 53 (6) 52 (6) 
% of female 67 52 60 65 63 
Height (women), cm  163(6) 164(6) 163 (6) 163 (6) 164 (6) 
Height (men), cm  176(7) 177(7) 176 (7) 176 (7) 177 (7) 
Weight, kg 83(18) 83(16) 84 (18) 83 (17) 82 (17) 
BMI 30(6) 29(5) 30(7) 30(6) 29(6) 
SBP, mmHg 131(22) 125(19) 132 (22) 128 (23) 126 (19) 
DBP, mmHg 80(12) 79(12) 80 (13) 79 (13) 79 (12) 
Smoking, % 32 25 34 29 25 
AT, % 44 34 46 38 36 
P. of diabetes, % 23 13 25 19 15 
P. of HF, % 9 3 10 7 4 
Prior MI, % 4 2 5 4 2 
Values corresponding to mean (standard deviation) or percentages. 
AT: antihypertension therapy. P.: prevalence. HF: heart failure. MI: myocardial infarction. 
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Basic – did not complete high school; Median – completed high school or equivalent; High – 
completed at least some college education. 
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Table 3. Age-, race-, and sex-specific incidence rates of AF per 1000 person-years, Atherosclerosis Risk in 
Communities Study, 1987-2014 
 White men White women African American men 
African American 
women 
Age group 
N. 
AF 
Person- 
Years IR 
N. 
AF 
Person- 
years IR 
N. 
AF 
Person- 
years IR 
N. 
AF 
Person- 
years IR 
45-54 25 13355 1.9 9 17483 0.5 4 4681 0.7 4 8397 0.5 
55-59 66 16223 4.1 30 19809 1.5 11 4817 2.3 13 8781 1.5 
60-64 132 21855 6.0 84 25581 3.3 23 5983 3.8 31 10641 2.9 
65-69 220 22324 9.9 169 26341 6.4 42 5952 7.1 56 10606 5.3 
70-74 279 18143 15.4 241 22001 11.0 51 4481 11.4 74 8449 8.8 
75-79 267 11198 23.8 224 13808 16.2 47 2378 19.8 68 4692 14.5 
80-84 198 5118 38.7 178 6605 26.9 24 943 25.5 40 2107 19.0 
85-89 73 1255 58.2 73 1904 38.4 10 233 42.9 21 557 37.7 
Crude rate 1262 109514 11.5 1008 133602 7.5 212 29478 7.2 308 54250 5.7 
Age-adjusted rate   11.3   7.3   8.1   6.1 
RR (95%CI)* 1 (Ref.) 0.64 (0.59, 0.70) 0.71 (0.62, 0.83) 0.54 (0.47, 0.61) 
IR: Incidence rate (per 1000 person-years). *Age-standardized rate ratio and 95% confidence interval 
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Table 4. Estimates (95% confidence intervals) of race- and sex-specific lifetime risk of AF 
conditional on survival free of AF to age 45, 55, 65, or 75, Atherosclerosis Risk in Communities 
study, 1987-2014. 
Survival 
free of AF White men White women African American men African American women 
age 45 36 (32, 38) 30 (26, 32) 21 (13, 24) 22 (16, 25) 
age 55 36 (32, 38) 30 (27, 32) 21 (13, 24) 22 (16, 25) 
age 65 35 (31, 37) 30 (26, 32) 22 (14, 26) 23 (17, 26) 
age 75 32 (28, 35) 26 (23, 29) 21 (12, 26) 21 (15, 26) 
Lifetime risk (%) is up to age 92. 
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Table 5. Age-, race-, sex-, income-, and education-specific incidence rates of AF per 1000 person-years, Atherosclerosis Risk in 
Communities Study, 1987-2014 
 White men White women African American men African American women 
Age group 
<$25
K 
$25K-
<$50K ≥$50K <$25K 
$25K-
<$50K ≥$50K <$25K ≥$25K <$25 ≥$25K 
45-54 1.3 2.1 1.6 0.9 0.7 0.2 0.9 0.8 0.6 0.3 
55-59 6.9 4.2 2.6 1.5 2.1 0.8 1.3 3.3 2.1 0.3 
60-64 7.1 6.0 5.7 2.7 3.4 3.4 5.1 2.5 3.8 1.1 
65-69 14.8 9.5 7.2 10.0 5.9 3.7 7.1 7.0 5.2 5.5 
70-74 19.3 14.6 14.8 12.4 10.4 9.7 13.4 9.1 9.1 8.1 
75-79 27.3 24.1 22.2 19.3 16.0 14.2 24.1 14.3 16.7 9.0 
80-84 30.6 41.5 41.0 31.8 23.6 23.4 28.1 21.4 22.4 9.1 
85-89 78.9 43.3 61.2 38.3 40.3 38.4 31.5 67.1 30.6 70.7 
Rate*  13.7 11.1 10.4 8.7 7.1 6.0 8.9 7.2 6.7 4.9 
RR  
(95%CI) 
** 
1 
(Ref.) 
0.81 
(0.70, 
0.94) 
0.76  
(0.65, 
0.88) 
1 
(Ref.) 
0.82  
(0.71, 
0.94) 
0.70  
(0.59, 
0.83) 
1 
(Ref.) 
0.80  
(0.60, 1.07) 
1 
(Ref.) 
0.73  
(0.56, 0.96) 
Age group Basic Median  High Basic Median  High Basic Median High Basic Median  High 
45-54 2.2 1.2 2.4 1.6 0.6 0.1 0.7 0.7 1.1 0.4 0.4 0.6 
55-59 4.1 5 3.2 3.0 1.4 1.2 1.1 3.8 2.3 1.0 1.9 1.7 
60-64 6.5 6.2 5.7 4.9 3.2 2.7 4.1 7.2 1.0 4.9 2.8 0.6 
65-69 12.7 11.1 7.7 11.0 6.1 4.7 7.8 9.6 4.2 7.8 4.2 3.3 
70-74 15.9 16.9 13.9 15.1 10.6 9.6 11.5 13.1 10.1 10.0 10.0 5.7 
75-79 25.7 26.3 20.9 25.0 15.5 12.7 25.9 15.3 13.7 15.3 11.2 16.5 
80-84 41.7 35.9 38.7 27.7 26.7 27.0 30.0 18.5 23.1 22.7 19.4 12.2 
85-89 65.2 62.1 51.4 51.5 39.5 28.2 45.8 19.2 60.0 41.8 29.8 39.7 
Rate*  12.5 12.1 10.2 10.6 7.1 6.0 8.9 8.7 6.3 7.4 5.7 4.7 
RR  
(95%CI) 
*** 
1 
(Ref.) 
0.96  
(0.83, 
1.12) 
0.81 
(0.70, 
0.94) 
1 
(Ref.) 
0.67  
(0.57, 
0.78) 
0.57  
(0.48, 
0.68) 
1 
(Ref.) 
0.97  
(0.70, 
1.35) 
0.71  
(0.5, 
1.00) 
1 
(Ref.) 
0.77  
(0.59, 
1.00) 
0.63  
(0.48, 
0.84) 
 
Basic – did not complete high school; Median – completed high school or equivalent; High – 
completed at least some college education. 
* Age-adjusted rate. 
** Age-standardized rate ratio and 95% confidence interval. Group of < $25K as reference. 
*** Age-standardized rate ratio and 95% confidence interval. Group of Basic as reference. 
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Table 6. Estimates (95% confidence intervals) of race-, sex, income-, and education-specific lifetime risk of AF conditional on 
survival free of AF to age 45, 55, 65, and 75, Atherosclerosis Risk in Communities study, 1987-2014 
 White men White women African American men African American women 
Survival 
free of AF <$25K 
$25K - 
<$50K ≥$50K <$25K 
$25K - 
<$50K ≥$50K <$25K ≥$25K <$25K ≥$25K 
age 45 
33  
(26, 37) 
35  
(30, 38) 
40  
(32, 45) 
31 
(26, 34) 
28 
(24, 31) 
28 
(20, 34) 
19 
(10, 22) 
25 
(6, 31) 
21 
(15, 24) 
26 
(2, 37) 
age 55 
34 
(27, 38) 
34 
(29, 37) 
40 
(32, 45) 
31  
(26, 34) 
29 
(24, 32) 
28 
(20, 35) 
19 
(11, 23) 
25 
(6, 32) 
22 
(16, 25) 
26 
(3, 38) 
age 65 
33 
(26, 37) 
33 
(28, 36) 
39 
(31, 45) 
32 
(27, 35) 
28 
(23, 31) 
28 
(19, 34) 
21 
(12, 25) 
25 
(6, 33) 
22 
(16, 25) 
28 
(4, 40) 
age 75 
30 
(22, 35) 
30 
(24, 34) 
37 
(28, 44) 
29 
(23, 33) 
24 
(19, 28) 
25 
(15, 32) 
21 
(11, 26) 
24 
(4, 34) 
21 
(15, 26) 
26 
(1, 41) 
Survival 
free of AF Basic Median High Basic Median High Basic Median High Basic Median High 
age 45 
34 
(26, 38) 
37 
(31, 40) 
36 
(30, 39) 
35 
(28, 40) 
29 
(25, 32) 
27 
(21, 30) 
19 
(10, 23) 
21 
(3, 27) 
24 
(1, 33) 
23 
(14, 27) 
20 
(9, 26) 
19 
(10, 25) 
age 55 
33 
(25, 37) 
37 
(31, 40) 
35 
(30, 39) 
34.6 
(27, 39) 
29 
(25, 32) 
27 
(21, 31) 
20 
(11, 24) 
21 
(3, 27) 
24 
(0, 33) 
23 
(14, 27) 
22 
(10, 28) 
19 
(10, 25) 
age 65 
33 
(25, 37) 
36 
(30, 39) 
34 
(28, 38) 
35 
(28, 40) 
29 
(24, 32) 
26 
(21, 31) 
22 
(13, 27) 
20  
(1, 27) 
25 
(1, 35) 
24 
(15, 29) 
22 
(10, 28) 
20 
(10, 26) 
age 75 
32 
(23, 38) 
33 
(26, 37) 
32 
(25, 36) 
31 
(23, 37) 
26 
(21, 29) 
23 
(17, 28) 
24 
(13, 30) 
16 
(0, 26) 
24 
(0, 38) 
23 
(13, 29) 
20 
(7, 28) 
19 
(9, 26) 
Basic – did not complete high school; Median – completed high school or equivalent; High – completed 
at least some college education. 
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Table 7. Estimates (95% confidence intervals) of lifetime risk of AF conditional on survival free of AF to 
age 45, 55, 65, or 75 by quartiles of 5-year predicted risk, Atherosclerosis Risk in Communities Study, 
1987-2014  
Survival 
free of AF 
Q1 
Predicted risk ≤ 0.4% 
Q2 
0.4% < Predicted risk ≤ 0.8% 
Q3 
0.8% < Predicted risk ≤ 1.5% 
Q4 
Predicted risk > 1.5% 
age 45 11 (8, 13) 25 (12, 33) 29 (25, 32) 37 (32, 43) 
age 55 11 (8, 13) 25 (12, 33) 29 (25, 31) 35 (32, 37) 
age 65 10 (7, 12) 24 (11, 33) 28 (25, 31) 34 (31, 36) 
age 75 5 (2,  8)                22 (8, 33) 25 (21, 28) 31 (28, 33) 
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Figure 1. Race- and sex-specific cumulative incidence of AF, Atherosclerosis Risk in 
Communities Study, 1987-2014.  
Lifetime risk is cumulative risk through 92 years of age.  
AAM: African American men; AAW: African American women; WM: white men; WW: white 
women 
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Figure 2. Cumulative incidence of AF from age 45 to 92 by income, education, race and sex, 
Atherosclerosis Risk in Communities Study, 1987-2014.  
A: By income categories in whites. B: By income categories in African Americans. C: By 
education categories in whites. D: By education categories in African Americans.  
AAM: African American men. AAW: African American women. WM: white men. WW: white 
women. 
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Figure 3. Cumulative incidence of AF from age 45 to 92 by quartiles of predicted 5-year 
risk of AF, Atherosclerosis Risk in Communities Study, 1987-2014.  
Q1: predicted risk ≤ 0.4%. Q2: 0.4% < predicted risk ≤ 0.8%. Q3: 0.8% < predicted risk ≤ 1.5%. 
Q4: predicted risk > 1.5%. 
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